Sapana K Kothary, DDS
Dentist · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 4
- 2 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
4 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kothary’s office at (408) 266-6144 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A45123 · Deceased
Licence status: Deceased · since 1988 · University of Rome-La Sapienza Faculty of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 13 Part D prescriptions in 2019. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2019 | 13 | 11 | 0% (0) | 0% | $126 |
| 2018 | 19 | 15 | None | None | $294 |
| 2017 | 30 | 22 | None | 0% | $317 |
| 2016 | 15 | 14 | None | 0% | $267 |
| 2015 | 34 | 30 | None | None | $436 |
| 2014 | 36 | 31 | None | None | $463 |
| 2013 | 35 | 33 | 0% (0) | None | $470 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2017: 1 drug
| Clindamycin | 13 | $183 | $14 |
2015: 1 drug
| Clindamycin | 17 | $233 | $14 |
2014: 1 drug
| Clindamycin | 13 | $218 | $17 |
2013: 1 drug
| Clindamycin | 18 | $309 | $17 |
Money from drug and device companies
$507 in 2025
| 2025 | 1 | 7 | None | $507 |
| 2024 | 2 | 25 | $60 | $769 |
| 2023 | 1 | 4 | None | $179 |
| 2022 | 2 | 11 | $10 | $485 |
| 2021 | 1 | 1 | None | $26 |
| 2020 | 2 | 3 | None | $261 |
| 2019 | 4 | 5 | None | $304 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Align Technology | Invisalign | $507 | 7 payments
|
See all 7 published payments
| Align Technology | Education · 2025-12-05 | Invisalign | $350 |
| Align Technology | Meals · 2025-07-29 | Invisalign | $20 |
| Align Technology | Meals · 2025-07-16 | Invisalign | $60 |
| Align Technology | Meals · 2025-06-02 | Invisalign | $26 |
| Align Technology | Meals · 2025-05-14 | Invisalign | $1 |
| Align Technology | Meals · 2025-05-14 | Invisalign | $22 |
| Align Technology | Meals · 2025-03-12 | Invisalign | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $769
| Align Technology | Invisalign | $693 | 24 payments
|
| Straumann USA | None | $76 | 1 payment
|
2023: $179
| Align Technology | Invisalign System - Moderate | $179 | 4 payments
|
2022: $485
| Align Technology | Invisalign | $465 | 10 payments
|
| Straumann USA | None | $20 | 1 payment
|
2021: $26
| Straumann USA | None | $26 | 1 payment
|
2020: $261
| Align Technology | Invisalign | $250 | 2 payments
|
| 3m | Clarity Aligner | $12 | 1 payment
|
2019: $304
| Zimmer Biomet Holdings | Bellatek | $154 | 2 payments
|
| Straumann USA | None | $125 | 1 payment
|
| Dentsply Sirona | Celtra Duo | $13 | 1 payment
|
| MIS Implants Technologies | Implant Dentistry | $12 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Merck Sharp & Dohme LLC · Oral Hpv Infection - Progress Study Prevalence of Oral Hpv Infection, A Global Assessment · 2022 | This clinician | $6,150 |
| Merck Sharp & Dohme LLC · Study Name# Oral Hpv Infection - Progress Study Prevalence of Oral Hpv Infection, A Global Assessment · 2023 | This clinician | $861 |
Professional record
- NPI
- 1184874364
- Licence
- CA 45123California A45123: Deceased
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 122300000X (122300000X)
- Mailing address
- 1241 Meridian Ave, San Jose, CA, 95125
- NPI first listed
- 2008-09-24
- NPI last updated
- 2021-02-25
- NPI record certified
- 2021-02-02
This is when the NPI record was last certified, not a medical board exam.